PPI1R1A: A Protein Regulator of Inflammation and Apoptosis (G5502)

Target Name: PPP1R1A

NCBI ID: G5502

PPP1R1A

PPI1R1A: A Protein Regulator of Inflammation and Apoptosis

PPI1R1A (IPP-1), also known as protamine IPP-1, is a protein that is expressed in various tissues throughout the body, including the brain, pancreas, and gastrointestinal tract. It is a key regulator of the inflammation response and has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The Importance of PPI1R1A

PPI1R1A is a protein that plays a critical role in the regulation of inflammation and has been shown to be involved in a number of important biological processes. One of its key functions is to regulate the production of pro-inflammatory cytokines, which are molecules that play a central role in the inflammatory response.

PPI1R1A has been shown to be involved in the regulation of cytokine production by inhibiting the activity of the nuclear factor kappa B (NFKB), a protein that plays a central role in the regulation of inflammation. This protein has been shown to promote the production of pro-inflammatory cytokines, such as TNF-alpha, IL-1, and IL-6, by inhibiting the activity of different inhibitors.

In addition to its role in regulating cytokine production, PPI1R1A has also been shown to be involved in the regulation of the apoptosis (programmed cell death), which is a natural process that helps remove damaged or dysfunctional cells from the body.

Implications for the Development of Therapeutic Strategies

The potential therapeutic applications of PPI1R1A are vast, as its involvement in the regulation of inflammation and apoptosis makes it an attractive target for a variety of therapeutic strategies.

One of the most promising strategies for the treatment of PPI1R1A-related diseases is the use of small molecules that can inhibit the activity of PPI1R1A. This approach has been shown to be effective in a variety of models, including the regulation of inflammatory cytokine production and the regulation of apoptosis.

Another approach that is being explored is the use of drugs that can modulate the expression of PPI1R1A. This approach has the advantage of being less invasive than using small molecules, and has the potential to be more effective in some cases.

Conclusion

PPI1R1A is a protein that plays a critical role in the regulation of inflammation and apoptosis. Its potential therapeutic applications are vast and continue to be an area of active research. Further studies are needed to fully understand the role of PPI1R1A in disease and to develop effective therapeutic strategies for the treatment of PPI1R1A-related disorders.

Protein Name: Protein Phosphatase 1 Regulatory Inhibitor Subunit 1A

Functions: Inhibitor of protein-phosphatase 1. This protein may be important in hormonal control of glycogen metabolism. Hormones that elevate intracellular cAMP increase I-1 activity in many tissues. I-1 activation may impose cAMP control over proteins that are not directly phosphorylated by PKA. Following a rise in intracellular calcium, I-1 is inactivated by calcineurin (or PP2B). Does not inhibit type-2 phosphatases

The "PPP1R1A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PPP1R1A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets